Clinical Trials Logo
  1. Home
  2. Gout Flare
  3. NCT05522504

Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout

Gout Flare Clinical Trial

Official title:
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout

Clinical Trial Summary

The purpose of this study is to evaluate whether immune cells and their subtypes in peripheral blood affects the asymptomatic hyperuricemia, gout flare, intercritical gout and advanced gout.

Clinical Trial Description

A number of studies have reported that innate immunity cells (such as blood monocytes and neutrophils) play a crucial role in the initiation and amplification of gout flare resulted from MSU deposition in the joint or tissue, leading to release NLRP3 inflammasome-mediated production of bioactive IL-1β. Further investigation demonstrated the role of blood neutrophils might contribute to the resolution of gout flare by forming aggregated neutrophil extracellular traps. Recently, a few in vitro experiments have indicated that adaptive immunity may be involved in mechanisms of gout. However, a global understanding of blood immune responses underlying gout is still unclear. Thus, we want to investigate the relationship between immune cells and their subtypes in peripheral blood and the gout. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05522504
Study type Observational
Source Shanghai 10th People's Hospital
Contact Ai Peng, MD, PhD
Phone 86-21-66302524
Email pengai@tongji.edu.cn
Status Recruiting
Phase
Start date September 15, 2021
Completion date February 2023
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT03933007 - Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare Phase 4
Not yet recruiting NCT04069325 - Efficacy and Safety of Simiaowan in Prevention of Acute Flares in Chronic Gout Patients Initiating Febuxostat Therapy N/A
Recruiting NCT05586958 - Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients Phase 3
Active, not recruiting NCT06197828 - Novel Biomarkers for Early Renal Injury in Children With Sepsis
Recruiting NCT05586971 - Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients Phase 3
Not yet recruiting NCT04849312 - Prediction of 30-Day Readmission Using Machine Learning
Active, not recruiting NCT04784351 - Prediction of Expected Length of Hospital Stay Using Machine Learning
Active, not recruiting NCT05045742 - Prediction of Patient Deterioration Using Machine Learning
Completed NCT03203759 - Hospital-Level Care at Home for Acutely Ill Adults N/A
Recruiting NCT05936268 - Safety and Efficacy of Genakumab for Injection in Patients With Gout Flare Phase 2
Active, not recruiting NCT03621215 - The Effect of Tart Cherry Juice on Risk of Gout Attacks N/A
Recruiting NCT05658575 - Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare Phase 2/Phase 3
Recruiting NCT03524222 - Home Hospital for Suddenly Ill Adults N/A
Not yet recruiting NCT06273813 - Treatment of Topical Ketorolac Gel in Acute Gouty Flare Phase 1
Completed NCT04531280 - Rural Home Hospital: Proof of Concept N/A
Completed NCT05256303 - Rural Hospital-Level Care at Home for Acutely Ill Adults N/A
Not yet recruiting NCT06207045 - The Effects of Limb Elevation During Gout Flare Episodes N/A
Completed NCT04080570 - Remote Physician Care for Home Hospital Patients N/A